10 likes | 144 Views
New oral coagulants versus warfarin in patients with AF. RE-LY: dabigatran ; ROCKET AF: rivaroxaban ; ARISTOTLE : apixaban. Favors NOA Therapy. Favors Warfarin Therapy. Miller SC et al. Am J Cardiol 2012.
E N D
New oralcoagulants versus warfarin in patientswith AF RE-LY: dabigatran; ROCKET AF: rivaroxaban; ARISTOTLE: apixaban Favors NOA Therapy FavorsWarfarinTherapy Miller SC et al. Am J Cardiol 2012